Total: £ 56.28
Published Date: 2026-05-15 | Pages: 95 | Tables: 103 | Pharma & Healthcare
The global Shengagliptin Phosphate Tablets market was valued at US$ 12.50 million in 2025 and is anticipated to reach US$ 58.30 million by 2032, at a CAGR of 12.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Shengagliptin Phosphate Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sentagliptin Phosphate Tablets are a Class 1 innovative oral hypoglycemic drug independently developed in China, belonging to high‑selectivity DPP‑4 inhibitors. By inhibiting the activity of dipeptidyl peptidase 4, the drug delays the degradation of incretins in the human body and bidirectionally regulates the secretion of insulin and glucagon, so as to steadily control blood glucose levels. It exerts a mild hypoglycemic effect with a low risk of hypoglycemia and favorable medication safety and tolerance. It is mainly applied to improve blood glucose control in adult patients with type 2 diabetes, and can be used as monotherapy or in combination with hypoglycemic agents such as metformin. As a newly launched domestic innovative metabolic drug, Sentagliptin Phosphate Tablets diversify the clinical treatment options for type 2 diabetes in China and meet the long‑term management needs of chronic diseases. Supported by clinical promotion and favorable medical policies, it enjoys promising development prospects in the hypoglycemic drug market.In 2025, global Sentagliptin Phosphate Tablets production reached approximately 1.6 million bottles.
Sentagliptin Phosphate Tablets are a Class 1 innovative DPP-4 inhibitor independently developed in China. Relying on excellent clinical efficacy and safety, it has outstanding market competitiveness in the treatment of type 2 diabetes. As a new generation of highly selective preparation, the drug features an extremely low risk of hypoglycemia and good tolerance. It meets the clinical needs of elderly patients and those with combined high-risk factors. Meanwhile, it supports flexible combined medication regimens and can be used synergistically with a variety of hypoglycemic drugs, expanding clinical application scenarios. Supported by the National Major New Drug Creation Special Project, it enjoys a long patent protection period and a stable market life cycle. At present, the domestic DPP-4 inhibitor market faces fierce competition with coexisting imported original drugs and domestic generic drugs. As an innovative drug with differentiated advantages, Sentagliptin Phosphate Tablets is expected to gradually increase its market share through medical insurance access, clinical academic promotion and grassroots market penetration. With the growing demand for chronic disease management of diabetes and the continuous release of policy dividends for innovative drugs, this product will further enrich clinical treatment options, accelerate the import substitution of domestic innovative hypoglycemic drugs, and present remarkable long-term market development potential.
This report delivers a comprehensive overview of the global Shengagliptin Phosphate Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Shengagliptin Phosphate Tablets. The Shengagliptin Phosphate Tablets market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Shengagliptin Phosphate Tablets market comprehensively. Regional market sizes by Type, by Application, by Dosage Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Shengagliptin Phosphate Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cgenetech
Segment by Type
50mg
100mg
Segment by Dosage Form
Conventional Tablets
Immediate-release Oral Tablets
Segment by Combination Therapy
Combined With Metformin
Combined With Sulfonylureas
Segment by Sales Channel
Hospital
Retail
Online
by Application
Type 2 Diabetes Treatment
Blood Glucose Control
Chronic Disease Management
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Shengagliptin Phosphate Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Shengagliptin Phosphate Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Shengagliptin Phosphate Tablets Market Overview
1.1 Product Definition
1.2 Shengagliptin Phosphate Tablets by Type
1.2.1 Global Shengagliptin Phosphate Tablets Market Value by Type: 2025 vs 2032
1.2.2 50mg
1.2.3 100mg
1.3 Shengagliptin Phosphate Tablets by Dosage Form
1.3.1 Global Shengagliptin Phosphate Tablets Market Value by Dosage Form: 2025 vs 2032
1.3.2 Conventional Tablets
1.3.3 Immediate-release Oral Tablets
1.4 Shengagliptin Phosphate Tablets by Combination Therapy
1.4.1 Global Shengagliptin Phosphate Tablets Market Value by Combination Therapy: 2025 vs 2032
1.4.2 Combined With Metformin
1.4.3 Combined With Sulfonylureas
1.5 Shengagliptin Phosphate Tablets by Sales Channel
1.5.1 Global Shengagliptin Phosphate Tablets Market Value by Sales Channel: 2025 vs 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Shengagliptin Phosphate Tablets by Application
1.6.1 Global Shengagliptin Phosphate Tablets Market Value by Application: 2025 vs 2032
1.6.2 Type 2 Diabetes Treatment
1.6.3 Blood Glucose Control
1.6.4 Chronic Disease Management
1.6.5 Others
1.7 Global Shengagliptin Phosphate Tablets Market Size Estimates and Forecasts
1.7.1 Global Shengagliptin Phosphate Tablets Revenue 2021–2032
1.7.2 Global Shengagliptin Phosphate Tablets Sales 2021–2032
1.7.3 Global Shengagliptin Phosphate Tablets Market Average Price (2021–2032)
1.8 Assumptions and Limitations
2 Shengagliptin Phosphate Tablets Market Competition by Manufacturers
2.1 Global Shengagliptin Phosphate Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Shengagliptin Phosphate Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Shengagliptin Phosphate Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Shengagliptin Phosphate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Shengagliptin Phosphate Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Shengagliptin Phosphate Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Shengagliptin Phosphate Tablets, Date of Entry into the Industry
2.8 Global Shengagliptin Phosphate Tablets Market Competitive Situation and Trends
2.8.1 Global Shengagliptin Phosphate Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Shengagliptin Phosphate Tablets Players Market Share by Revenue
2.8.3 Global Shengagliptin Phosphate Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Shengagliptin Phosphate Tablets Market Scenario by Region
3.1 Global Shengagliptin Phosphate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Shengagliptin Phosphate Tablets Sales by Region: 2021–2032
3.2.1 Global Shengagliptin Phosphate Tablets Sales by Region: 2021–2026
3.2.2 Global Shengagliptin Phosphate Tablets Sales by Region: 2027–2032
3.3 Global Shengagliptin Phosphate Tablets Revenue by Region: 2021–2032
3.3.1 Global Shengagliptin Phosphate Tablets Revenue by Region: 2021–2026
3.3.2 Global Shengagliptin Phosphate Tablets Revenue by Region: 2027–2032
3.4 North America Shengagliptin Phosphate Tablets Market Facts & Figures by Country
3.4.1 North America Shengagliptin Phosphate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Shengagliptin Phosphate Tablets Sales by Country (2021–2032)
3.4.3 North America Shengagliptin Phosphate Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Shengagliptin Phosphate Tablets Market Facts & Figures by Country
3.5.1 Europe Shengagliptin Phosphate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Shengagliptin Phosphate Tablets Sales by Country (2021–2032)
3.5.3 Europe Shengagliptin Phosphate Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Shengagliptin Phosphate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Shengagliptin Phosphate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Shengagliptin Phosphate Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Shengagliptin Phosphate Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Shengagliptin Phosphate Tablets Market Facts & Figures by Country
3.7.1 Latin America Shengagliptin Phosphate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Shengagliptin Phosphate Tablets Sales by Country (2021–2032)
3.7.3 Latin America Shengagliptin Phosphate Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Shengagliptin Phosphate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Shengagliptin Phosphate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Shengagliptin Phosphate Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Shengagliptin Phosphate Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Shengagliptin Phosphate Tablets Sales by Type (2021–2032)
4.1.1 Global Shengagliptin Phosphate Tablets Sales by Type (2021–2026)
4.1.2 Global Shengagliptin Phosphate Tablets Sales by Type (2027–2032)
4.1.3 Global Shengagliptin Phosphate Tablets Sales Market Share by Type (2021–2032)
4.2 Global Shengagliptin Phosphate Tablets Revenue by Type (2021–2032)
4.2.1 Global Shengagliptin Phosphate Tablets Revenue by Type (2021–2026)
4.2.2 Global Shengagliptin Phosphate Tablets Revenue by Type (2027–2032)
4.2.3 Global Shengagliptin Phosphate Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Shengagliptin Phosphate Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Shengagliptin Phosphate Tablets Sales by Application (2021–2032)
5.1.1 Global Shengagliptin Phosphate Tablets Sales by Application (2021–2026)
5.1.2 Global Shengagliptin Phosphate Tablets Sales by Application (2027–2032)
5.1.3 Global Shengagliptin Phosphate Tablets Sales Market Share by Application (2021–2032)
5.2 Global Shengagliptin Phosphate Tablets Revenue by Application (2021–2032)
5.2.1 Global Shengagliptin Phosphate Tablets Revenue by Application (2021–2026)
5.2.2 Global Shengagliptin Phosphate Tablets Revenue by Application (2027–2032)
5.2.3 Global Shengagliptin Phosphate Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Shengagliptin Phosphate Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cgenetech
6.1.1 Cgenetech Company Information
6.1.2 Cgenetech Description and Business Overview
6.1.3 Cgenetech Shengagliptin Phosphate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cgenetech Shengagliptin Phosphate Tablets Product Portfolio
6.1.5 Cgenetech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Shengagliptin Phosphate Tablets Industry Chain Analysis
7.2 Shengagliptin Phosphate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Shengagliptin Phosphate Tablets Production Mode & Process Analysis
7.4 Shengagliptin Phosphate Tablets Sales and Marketing
7.4.1 Shengagliptin Phosphate Tablets Sales Channels
7.4.2 Shengagliptin Phosphate Tablets Distributors
7.5 Shengagliptin Phosphate Tablets Customer Analysis
8 Shengagliptin Phosphate Tablets Market Dynamics
8.1 Shengagliptin Phosphate Tablets Industry Trends
8.2 Shengagliptin Phosphate Tablets Market Drivers
8.3 Shengagliptin Phosphate Tablets Market Challenges
8.4 Shengagliptin Phosphate Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Shengagliptin Phosphate Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Shengagliptin Phosphate Tablets Market Value by Dosage Form (US$ Million), 2025 vs 2032
Table 3. Global Shengagliptin Phosphate Tablets Market Value by Combination Therapy (US$ Million), 2025 vs 2032
Table 4. Global Shengagliptin Phosphate Tablets Market Value by Sales Channel (US$ Million), 2025 vs 2032
Table 5. Global Shengagliptin Phosphate Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 6. Global Shengagliptin Phosphate Tablets Market Competitive Situation by Manufacturers in 2025
Table 7. Global Shengagliptin Phosphate Tablets Sales (Units) of Key Manufacturers (2021–2026)
Table 8. Global Shengagliptin Phosphate Tablets Sales Market Share by Manufacturers (2021–2026)
Table 9. Global Shengagliptin Phosphate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 10. Global Shengagliptin Phosphate Tablets Revenue Share by Manufacturers (2021–2026)
Table 11. Global Market Shengagliptin Phosphate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 12. Global Key Players of Shengagliptin Phosphate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 13. Global Key Manufacturers of Shengagliptin Phosphate Tablets, Manufacturing Sites and Headquarters
Table 14. Global Key Manufacturers of Shengagliptin Phosphate Tablets, Product Types and Applications
Table 15. Global Key Manufacturers of Shengagliptin Phosphate Tablets, Date of Entry into the Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Shengagliptin Phosphate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Shengagliptin Phosphate Tablets Revenue, 2025
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Shengagliptin Phosphate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Shengagliptin Phosphate Tablets Sales by Region (Units), 2021–2026
Table 21. Global Shengagliptin Phosphate Tablets Sales Market Share by Region (2021–2026)
Table 22. Global Shengagliptin Phosphate Tablets Sales by Region (Units), 2027–2032
Table 23. Global Shengagliptin Phosphate Tablets Sales Market Share by Region (2027–2032)
Table 24. Global Shengagliptin Phosphate Tablets Revenue by Region (US$ Million), 2021–2026
Table 25. Global Shengagliptin Phosphate Tablets Revenue Market Share by Region (2021–2026)
Table 26. Global Shengagliptin Phosphate Tablets Revenue by Region (US$ Million), 2027–2032
Table 27. Global Shengagliptin Phosphate Tablets Revenue Market Share by Region (2027–2032)
Table 28. North America Shengagliptin Phosphate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. North America Shengagliptin Phosphate Tablets Sales by Country (Units), 2021–2026
Table 30. North America Shengagliptin Phosphate Tablets Sales by Country (Units), 2027–2032
Table 31. North America Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2021–2026
Table 32. North America Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2027–2032
Table 33. Europe Shengagliptin Phosphate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Europe Shengagliptin Phosphate Tablets Sales by Country (Units), 2021–2026
Table 35. Europe Shengagliptin Phosphate Tablets Sales by Country (Units), 2027–2032
Table 36. Europe Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2021–2026
Table 37. Europe Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2027–2032
Table 38. Asia Pacific Shengagliptin Phosphate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Asia Pacific Shengagliptin Phosphate Tablets Sales by Region (Units), 2021–2026
Table 40. Asia Pacific Shengagliptin Phosphate Tablets Sales by Region (Units), 2027–2032
Table 41. Asia Pacific Shengagliptin Phosphate Tablets Revenue by Region (US$ Million), 2021–2026
Table 42. Asia Pacific Shengagliptin Phosphate Tablets Revenue by Region (US$ Million), 2027–2032
Table 43. Latin America Shengagliptin Phosphate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Latin America Shengagliptin Phosphate Tablets Sales by Country (Units), 2021–2026
Table 45. Latin America Shengagliptin Phosphate Tablets Sales by Country (Units), 2027–2032
Table 46. Latin America Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2021–2026
Table 47. Latin America Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2027–2032
Table 48. Middle East and Africa Shengagliptin Phosphate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Middle East and Africa Shengagliptin Phosphate Tablets Sales by Country (Units), 2021–2026
Table 50. Middle East and Africa Shengagliptin Phosphate Tablets Sales by Country (Units), 2027–2032
Table 51. Middle East and Africa Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2021–2026
Table 52. Middle East and Africa Shengagliptin Phosphate Tablets Revenue by Country (US$ Million), 2027–2032
Table 53. Global Shengagliptin Phosphate Tablets Sales (Units) by Type (2021–2026)
Table 54. Global Shengagliptin Phosphate Tablets Sales (Units) by Type (2027–2032)
Table 55. Global Shengagliptin Phosphate Tablets Sales Market Share by Type (2021–2026)
Table 56. Global Shengagliptin Phosphate Tablets Sales Market Share by Type (2027–2032)
Table 57. Global Shengagliptin Phosphate Tablets Revenue (US$ Million) by Type (2021–2026)
Table 58. Global Shengagliptin Phosphate Tablets Revenue (US$ Million) by Type (2027–2032)
Table 59. Global Shengagliptin Phosphate Tablets Revenue Market Share by Type (2021–2026)
Table 60. Global Shengagliptin Phosphate Tablets Revenue Market Share by Type (2027–2032)
Table 61. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Type (2021–2026)
Table 62. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Type (2027–2032)
Table 63. Global Shengagliptin Phosphate Tablets Sales (Units) by Application (2021–2026)
Table 64. Global Shengagliptin Phosphate Tablets Sales (Units) by Application (2027–2032)
Table 65. Global Shengagliptin Phosphate Tablets Sales Market Share by Application (2021–2026)
Table 66. Global Shengagliptin Phosphate Tablets Sales Market Share by Application (2027–2032)
Table 67. Global Shengagliptin Phosphate Tablets Revenue (US$ Million) by Application (2021–2026)
Table 68. Global Shengagliptin Phosphate Tablets Revenue (US$ Million) by Application (2027–2032)
Table 69. Global Shengagliptin Phosphate Tablets Revenue Market Share by Application (2021–2026)
Table 70. Global Shengagliptin Phosphate Tablets Revenue Market Share by Application (2027–2032)
Table 71. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Application (2021–2026)
Table 72. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Application (2027–2032)
Table 73. Cgenetech Company Information
Table 74. Cgenetech Description and Business Overview
Table 75. Cgenetech Shengagliptin Phosphate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 76. Cgenetech Shengagliptin Phosphate Tablets Product
Table 77. Cgenetech Recent Developments/Updates
Table 78. Key Raw Materials Lists
Table 79. Raw Materials Key Suppliers Lists
Table 80. Shengagliptin Phosphate Tablets Distributors List
Table 81. Shengagliptin Phosphate Tablets Customers List
Table 82. Shengagliptin Phosphate Tablets Market Trends
Table 83. Shengagliptin Phosphate Tablets Market Drivers
Table 84. Shengagliptin Phosphate Tablets Market Challenges
Table 85. Shengagliptin Phosphate Tablets Market Restraints
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Product Picture of Shengagliptin Phosphate Tablets
Figure 2. Global Shengagliptin Phosphate Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Shengagliptin Phosphate Tablets Market Share by Type: 2025 & 2032
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Shengagliptin Phosphate Tablets Market Value by Dosage Form (US$ Million), 2021–2032
Figure 7. Global Shengagliptin Phosphate Tablets Market Share by Dosage Form: 2025 vs 2032
Figure 8. Conventional Tablets Product Picture
Figure 9. Immediate-release Oral Tablets Product Picture
Figure 10. Global Shengagliptin Phosphate Tablets Market Value by Combination Therapy (US$ Million), 2021–2032
Figure 11. Global Shengagliptin Phosphate Tablets Market Share by Combination Therapy: 2025 vs 2032
Figure 12. Combined With Metformin Product Picture
Figure 13. Combined With Sulfonylureas Product Picture
Figure 14. Global Shengagliptin Phosphate Tablets Market Value by Sales Channel (US$ Million), 2021–2032
Figure 15. Global Shengagliptin Phosphate Tablets Market Share by Sales Channel: 2025 vs 2032
Figure 16. Hospital Product Picture
Figure 17. Retail Product Picture
Figure 18. Online Product Picture
Figure 19. Global Shengagliptin Phosphate Tablets Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Shengagliptin Phosphate Tablets Market Share by Application: 2025 & 2032
Figure 21. Type 2 Diabetes Treatment
Figure 22. Blood Glucose Control
Figure 23. Chronic Disease Management
Figure 24. Others
Figure 25. Global Shengagliptin Phosphate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Shengagliptin Phosphate Tablets Market Size (US$ Million), 2021–2032
Figure 27. Global Shengagliptin Phosphate Tablets Sales (Units), 2021–2032
Figure 28. Global Shengagliptin Phosphate Tablets Average Price (US$/Unit), 2021–2032
Figure 29. Shengagliptin Phosphate Tablets Report Years Considered
Figure 30. Shengagliptin Phosphate Tablets Sales Share by Manufacturers in 2025
Figure 31. Global Shengagliptin Phosphate Tablets Revenue Share by Manufacturers in 2025
Figure 32. Top 5 and Top 10 Global Shengagliptin Phosphate Tablets Players: Market Share by Revenue in Shengagliptin Phosphate Tablets in 2025
Figure 33. Shengagliptin Phosphate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 34. Global Shengagliptin Phosphate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 35. North America Shengagliptin Phosphate Tablets Sales Market Share by Country (2021–2032)
Figure 36. North America Shengagliptin Phosphate Tablets Revenue Market Share by Country (2021–2032)
Figure 37. United States Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Canada Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Europe Shengagliptin Phosphate Tablets Sales Market Share by Country (2021–2032)
Figure 40. Europe Shengagliptin Phosphate Tablets Revenue Market Share by Country (2021–2032)
Figure 41. Germany Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. France Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. U.K. Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Italy Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Russia Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Asia Pacific Shengagliptin Phosphate Tablets Sales Market Share by Region (2021–2032)
Figure 47. Asia Pacific Shengagliptin Phosphate Tablets Revenue Market Share by Region (2021–2032)
Figure 48. China Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Japan Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. South Korea Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. India Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Australia Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. China Taiwan Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Southeast Asia Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America Shengagliptin Phosphate Tablets Sales Market Share by Country (2021–2032)
Figure 56. Latin America Shengagliptin Phosphate Tablets Revenue Market Share by Country (2021–2032)
Figure 57. Mexico Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Colombia Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Middle East and Africa Shengagliptin Phosphate Tablets Sales Market Share by Country (2021–2032)
Figure 62. Middle East and Africa Shengagliptin Phosphate Tablets Revenue Market Share by Country (2021–2032)
Figure 63. Turkey Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Saudi Arabia Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. UAE Shengagliptin Phosphate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. Global Sales Market Share of Shengagliptin Phosphate Tablets by Type (2021–2032)
Figure 67. Global Revenue Market Share of Shengagliptin Phosphate Tablets by Type (2021–2032)
Figure 68. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Type (2021–2032)
Figure 69. Global Sales Market Share of Shengagliptin Phosphate Tablets by Application (2021–2032)
Figure 70. Global Revenue Market Share of Shengagliptin Phosphate Tablets by Application (2021–2032)
Figure 71. Global Shengagliptin Phosphate Tablets Price (US$/Unit) by Application (2021–2032)
Figure 72. Shengagliptin Phosphate Tablets Value Chain
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed